SQUAWK/NEWS
Menu
Live News EQUITY M impact

Gilead Sciences 13D Filing

Gilead Sciences Inc. files amended Schedule 13D with the SEC. The filing indicates a change in beneficial ownership.

GILD

Filed: 2026-05-27 AccNo: 0001123292-26-000750 Size: 28 KB